BTM Topic Modeling Approach to Named Entity Linking
Menglu You +4 more
openaire +1 more source
How to ‘survive’ after graduating in science or engineering: Becoming an academic administrator
Abstract This is the eighth article in the series ‘Survival Skills for Scientists’; previous papers were published in the Journal of Materials Education. Here I describe my views, based partly on personal experience, about pursuing an alternative career path within academia: becoming an administrator (e.g., Department Chair, Dean, Vice‐President ...
Federico Rosei
wiley +1 more source
From literature to biodiversity data: mining arthropod organismal traits with machine learning. [PDF]
Cornelius J +5 more
europepmc +1 more source
Post‐LECA Origin and Diversification of an Axonemal Outer Arm Dynein Motor
ABSTRACT Dyneins were present in the last eukaryotic common ancestor (LECA) and play key roles in eukaryotic biology. Axonemal dyneins form the inner and outer arms that power ciliary beating, and it has long been recognized that outer arms in some organisms contain two different heavy chain motors, whereas those from other species contain a third unit
Stephen M. King
wiley +1 more source
SNOMED CT entity linking challenge. [PDF]
Davidson R +11 more
europepmc +1 more source
PharmVar GeneFocus: CYP1A2—Clinical Impact, Genetic Variation, and Updated Nomenclature
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human CYP1A2 gene. CYP1A2 plays a crucial role in the biotransformation of several commonly used drugs, including antipsychotics, antidepressants, anxiolytics, and methylxanthines.
Katalin Monostory +13 more
wiley +1 more source
Ontology-Based Medication Named Entity Recognition Using Pretrained Transformer Models From a Thai Hospital: Model Fine-Tuning and Validation Study. [PDF]
Isaradech N +3 more
europepmc +1 more source
Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review
Interest in ayahuasca and its main component, N,N‐Dimethyltryptamine (DMT), has currently moved from historical and experimental use into modern clinical development. Yet, current evidence is fragmented, and systematic mapping of trial methods and design choices remains limited.
Tijana Stojanović +4 more
wiley +1 more source
Bangla MedER: Multi-BERT ensemble approach for the recognition of Bangla medical entity. [PDF]
Aurpa TT +6 more
europepmc +1 more source

